WebApr 9, 2024 · Cholangiocarcinoma, described as a malignancy that arises from the biliary tract epithelia, is the second most common primary liver malignancy. Cholangiocarcinoma can be divided into intrahepatic, hilar (HCCA) and distal cholangiocarcinoma according to the tumor location in the biliary tree. WebSpecifically, the biliary patency times for Bismuth type Ⅲ and Ⅳ were 7.5±1.1 and 6.1±1.3 months, respectively. The biliary patency time was around 3.3±0.7 months in the photodynamic only group and 7.9±0.9 months in the combined treatment group (P=0.017). Conclusion PDT for Bismuth Ⅲ-Ⅳ malignant biliary obstruction is safe and ...
Prognostic impact of the Bismuth-Corlette classification: …
WebTreatment of hilar cholangiocarcinoma of Bismuth-Corlette type III with hepaticojejunostomy Contemp Oncol (Pozn). 2013;17 (3):298-301. doi: 10.5114/wo.2013.35274. Epub 2013 Jun 28. Authors Bao-Chun Lu 1 , Pei-Tu Ren 1 Affiliation 1 Department of Hepatobiliary Surgery, Shaoxing People's Hospital, Zhejiang, … Web肝门部胆管癌根治术及远期疗效肝门部胆管癌根治术及远期疗效史宪杰教授史宪杰教授中国人民解放军总医院中国人民解放军总医院肝胆外科肝胆外科肝胆外科肝胆外科 肝门部胆管癌的外科手术治疗肝门部胆管癌的外科手术治疗n肝门部胆管癌肝门部胆管癌 概述概述n,文库 … phil holland boston
Cholangiocarcinoma – Bismuth Type IV - ScienceDirect
WebApr 10, 2024 · BackgroundThe Mayo protocol for liver transplantation in patients with unresectable perihilar cholangiocarcinoma is based on strict selection and neoadjuvant chemoradiotherapy. The role of neoadjuvant chemoradiotherapy in this scenario remains unclear. The aim of this study was to compare outcomes after transplantation for perihilar … WebJun 5, 2024 · Cholangiocarcinoma, the second most common hepatobiliary malignancy after hepatocellular carcinoma, is a heterogeneous disease entity with widely varying radiologic features, clinical behavior, and treatment approaches. In the detection, characterization, staging, and resectability assessment of cholangiocarcinoma, imaging … WebCholangiocarcinoma (CC) is the second most common tumor of the liver, originating from the biliary system with increasing incidence and mortality worldwide. Several new classifications review the significance of tumor localization, site of origin, proliferation and biomarkers in the intrahepatic, perihilar and distal forms of the lesion. ... phil holland alvarez